Epilepsy & Seizures
Conference Coverage
App Identifies Stress and Missed Sleep as Seizure Triggers
BOSTON—Research using an Apple Watch app to track seizures in people with epilepsy finds that common triggers include stress and...
Conference Coverage
Extrapolation of AED Efficacy Data From Adults to Pediatric Patients
BOSTON—Across a likely spectrum of syndromes with generalized seizures, the effect of adjunctive antiepileptic drug (AED)...
Literature Review
Anxiety and Depressive Disorders May Be Equally Prevalent in Patients With Epilepsy
Contrary to the widespread belief that depressive disorders are more common than anxiety disorders among people with epilepsy, these psychiatric...
Conference Coverage
ACT2: Noninvasive vagus nerve stimulation benefits episodic cluster headache
BOSTON – Noninvasive vagus nerve stimulation proved safe and effective for the treatment of episodic cluster headaches.
From the Journals
High allele level linked to lamotrigine-induced SCAR
Could higher frequency of alleles associated with drug-induced severe cutaneous adverse reactions be specific to ethnicity?
Video
Anup Patel, MD
Dr. Patel discussed efficacy of cannabidiol in patients with Lennox-Gastaut syndrome at the AAN 2017.
Video
Barbara Jobst, MD
At AAN 2017, Dr. Jobst describes the effectiveness of responsive neurostimulation for medically intractable epilepsy.
Conference Coverage
Cannabidiol cuts drop seizure frequency in Lennox-Gastaut syndrome
BOSTON – Two trials show drop seizure reductions of 37%-44% with cannabidiol in patients with a median of 70-plus drop seizures per month.
Video
VIDEO: Cannabidiol reduces convulsive seizures in Dravet syndrome
BOSTON – Adjunctive treatment with cannabidiol significantly reduced convulsive seizure frequency in Dravet syndrome patients.
Conference Coverage
VIDEO: Big research trials at AAN bring up important cost decisions
BOSTON – How will neurologists strike a balance between new drugs’ improved efficacy and safety and their affordability for patients?
Conference Coverage
New guideline: Address GTCS frequency to reduce SUDEP risk
BOSTON – Generalized tonic-clonic seizures are a major risk factor for sudden unexpected death in epilepsy (SUDEP).